Pacific Biosciences of California Inc
NASDAQ:PACB
Pacific Biosciences of California Inc
NASDAQ:PACB
Price:
1.12
USD
-7.44%
Market Closed
Market Cap:
$338.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
US |
|
Doximity Inc
NYSE:DOCS
|
US |
|
Star Entertainment Group Ltd
ASX:SGR
|
AU |
|
Zurich Insurance Group AG
SIX:ZURN
|
CH |
Wall St Price Targets
PACB Price Targets Summary
Pacific Biosciences of California Inc
Pacific Biosciences of California Inc
Wall Street analysts forecast PACB stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for PACB is 2.51 USD with a low forecast of 1.52 USD and a high forecast of 3.15 USD.
Lowest Forecast
Price Target
1.52
USD
35% Upside
Average Forecast
Price Target
2.51
USD
124% Upside
Highest Forecast
Price Target
3.15
USD
181% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PACB's stock price target?
Price Target
2.51
USD
2.51
USD
According to Wall Street analysts, the average 1-year price target for PACB is 2.51 USD with a low forecast of 1.52 USD and a high forecast of 3.15 USD.
What is the Revenue forecast for Pacific Biosciences of California Inc?
Projected CAGR
22%
22%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 7 years is 22%.
